Bexson Biomedical Closes $4.8M Series A Financing To Develop Wearable Ketamine Technology
Pharmaceutical startup Bexson Biomedical confirmed Monday the closing an oversubscribed Series A funding round. The $4.8
Pharmaceutical startup Bexson Biomedical confirmed Monday the closing an oversubscribed Series A funding round. The $4.8
According to Emmanuel Smadja, chief executive officer of MPOWER, Covid-19 has created financial stress for
The provider of loans to “high-promise” international and DACA students will look to add new
Being WBENC certified enterprise offers Accel with the credentials that corporations know, belief and want